Jan 31 (Reuters) - UG Healthcare Corporation Ltd : * SEES NET LOSS FOR HY23 * EXPECTED RESULT DUE TO HIGHER OPERATING EXPENSES AT UPSTREAM MANUFACTURING OF DISPOSABLE EXAMINATION GLOVES, AMONG OTHERS
By Brendan Pierson Jan 30 (Reuters) - Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court
Jan 30 (Reuters) - Gamida Cell Ltd: * GAMIDA CELL LTD - HAS DETERMINED TO CANCEL SPECIAL MEETING OF SHAREHOLDERS PREVIOUSLY SCHEDULED FOR FEBRUARY 14, 2023 Source text: (https://bit.ly/3JtPq1B)
Jan 30 (Reuters) - Evoke Pharma Inc: * EVOKE ANNOUNCES TEVA ENDS PURSUIT OF PARAGRAPH IV ANDA AGAINST GIMOTI * EVOKE PHARMA - IN ADDITION, NO FUTURE ANDA FILER WILL BE ELIGIBLE TO RECEIVE 180-DAY
Jan 30 (Reuters) - Daiichi Sankyo Co Ltd: * TROPION-LUNG07 PHASE 3 TRIAL INITIATED TO EVALUATE DATOPOTAMAB DERUXTECAN IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC
Jan 30 (Reuters) - May & Baker Nigeria PLC: * MAY & BAKER NIGERIA PLC- QTRLY GRP PBT FROM CONTINUING OPERATIONS 414.4 MILLION NAIRA VERSUS 162.7 MILLION NAIRA * MAY & BAKER NIGERIA PLC - QTRLY GROUP
GENEVA (Reuters) - The world is "dangerously unprepared" for future pandemics, the International Federation of the Red Cross and Red Crescent Societies (IFRC) say in a report published on Monday,
Jan 30 (Reuters) - Alterity Therapeutics Ltd: * ALTERITY’S ATH434 PREVENTS LOSS OF BRAIN CELLS IN PARKINSON’S DISEASE ANIMAL MODEL Further company coverage:
Jan 30 (Reuters) - Bionomics Ltd: * BIONOMICS LTD- HAS SUFFICIENT CASH RUNWAY TO SUPPORT ITS ONGOING ACTIVITIES AND UPCOMING MILESTONES WITH RUNWAY TO AT LEAST MID-2024 Further company coverage:
30 January 2023 11:07 a.m. All figures in US dollars. Novartis AG is expected to show a decrease in its fourth quarter earnings to $1.40 per share according to the mean Refinitiv estimate from nine